跳至主要内容
临床试验/CTRI/2020/02/023290
CTRI/2020/02/023290尚未招募1 期

Randomized, Controlled, Clinical Study to evaluate the efficacy of Pratham Trifala Rasayana as adjuvant therapy in Mutraghata with special reference to Chronic Renal Failure.

Sanjivani Jadhao Rathod0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Pre diagnosed patients of CKD of Stage I to III
  • 2. Both sexes male and female.
  • 3. Willing to Consent & Participate.
  • 4. Age 25 to 65 years.
  • 5. Patients having classical sign and symptoms of CKD such as Shotha (oedema), fatigability (weakness), Swaskashtata (Dyspnoea), anannabhilasha (anorexia), Panduta (less haemoglobin) etc.

排除标准

  • 1. Acute Renal Failure
  • 2. Uremic Coma
  • 3. Known Patients of Renal Artery Stenosis
  • 4. Age < 25 and > 65 years.
  • 5. Patients of Carcinoma
  • 6. Participate in other clinical trial within 30 days prior to this trial.
  • 7. History of previous kidney transplant.
  • 8. HIV and VDRL infected patients will be excluded.

研究者

发起方
Sanjivani Jadhao Rathod

相似试验

To evaluate the efficacy of pratham triphala rasayan... | 临床试验